46 results
8-K
MBRX
Moleculin Biotech Inc
19 Mar 24
Moleculin Announces Reverse Stock Split
4:31pm
”) special meeting of stockholders completed on October 3, 2023, the stockholders of the Company approved an amendment to the Company’s amended and restated … , as determined by the Company’s board of directors in its sole discretion prior to the one-year anniversary of the special meeting.
Pursuant
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
this 10 day period pursuant to Nasdaq Listing Rule 5810(c)(3)(G).
On October 3, 2023, the Company held a Special Meeting of Stockholders … (the "Special Meeting"). The Company's stockholders granted the Board of Directors the authority to affect an amendment to the Company’s amended and restated
8-K
MBRX
Moleculin Biotech Inc
14 Feb 24
Submission of Matters to a Vote of Security Holders
4:33pm
Holders.
On February 14, 2024, the Company held a Special Meeting of Stockholders (the "Special Meeting"). As of December 26, 2023, the record date … for the Special Meeting, there were 33,412,696 shares of common stock issued and outstanding and entitled to vote on the proposals presented at the Special
424B5
8cc h6cnpzjsqle3gf0h
22 Dec 23
Prospectus supplement for primary offering
5:00pm
8-K
EX-3.1
s09uvot5pfx237h
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-10.1
bvujrj9 bsdc
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
o2smp8o
6 Oct 23
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
4rhrds3 ngzb7p322mqn
21 Aug 23
Amendments to Articles of Incorporation or Bylaws
5:17pm
8-K
EX-3.1
7xi68on qvw8zb
21 Aug 23
Amendments to Articles of Incorporation or Bylaws
5:17pm
8-K
EX-3.1
pozjvd193j9 nys
17 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:30pm
424B5
tpjvpbi95p 2mg
25 Jun 21
Prospectus supplement for primary offering
5:26pm